Glomerular epithelial stem cells: the good, the bad, and the ugly.
Global glomerulosclerosis with loss of podocytes in humans is typical of end-stage renal pathology. Although mature podocytes are highly differentiated and nondividing, converging evidence from experimental and clinical data suggests adult stem cells within Bowman's capsule can rescue some of this loss. Glomerular epithelial stem cells generate podocytes during kidney growth and regenerate podocytes after injury, thus explaining why various glomerular disorders undergo remission occasionally. This regenerative process, however, is often inadequate because of inefficient proliferative responses by glomerular epithelial stem cells with aging or in the setting of focal segmental glomerulosclerosis. Alternatively, an excessive proliferative response by glomerular epithelial stem cells after podocyte injury can generate new lesions such as extracapillary crescentic glomerulonephritis, collapsing glomerulopathy and tip lesions. Better understanding of the mechanisms that regulate growth and differentiation of glomerular epithelial stem cells may provide new clues for prevention and treatment of glomerulosclerosis.
Lasagni
Laura
L
Excellence Centre for Research, Transfer and High Education for the development of De Novo Therapies (DENOTHE), University of Florence, Florence, Italy.
Romagnani
Paola
P
D053687:Adult Stem Cells / Q000502:physiology*; D000818:Animals; D005921:Glomerulonephritis / Q000503:physiopathology*; D006801:Humans; D007678:Kidney Glomerulus / Q000166:cytology*; D012038:Regeneration; D019459:Urothelium / Q000166:cytology / Q000502:physiology*